US2011002997A1PendingUtilityA1
Photoinitiated tissue filler
Est. expiryAug 1, 2027(~1 yrs left)· nominal 20-yr term from priority
A61P 17/02A61K 8/8152A61K 2800/91A61K 2800/81A61K 8/02A61L 27/50A61Q 19/00A61L 27/26
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Visible light-activated polymer cosmetic filler preparations useful in a variety of applications are provided. In some embodiments, the photo-activated polymer composition comprises a conventional polymeric material, such as HA, together with a modified, cross-linkable polymer, such as PEG or PEODA, to permit the formation of crosslinks within the polymer matrix in situ on exposure to a visible light source, such as an IPL device. The preparations provide for a more stabilized composition that is contourable during gelation.
Claims
exact text as granted — not AI-modified1 - 36 . (canceled)
37 . A method of repairing or augmenting soft tissue in a subject, the method comprising a. injecting into a subject in need thereof a composition comprising a biodegradable, polymerizable macromer, the macromer comprising a water soluble polymer modified with one or more biodegradable moieties; and b. polymerizing the macromer to provide a hydrogel wherein the hydrogel to soft tissue have a normalized compliance ratio of from about 0.05 to about 3, thus repairing or augmenting the soft tissue.
38 . The method of claim 37 , wherein the compliance ratio is from about 0.1 to about 2.0 relative to the soft tissue.
39 . The method of claim 38 , wherein the compliance ratio is from about 0.1 to about 1.0 relative to the soft tissue.
40 . The method of claim 37 , wherein the macromer is polymerized by irradiating through the skin of the subject with visible light.
41 . The method of claim 37 , wherein the subject is irradiated with visible light for from about 10 seconds to about 120 seconds.
42 . The method of claim 41 , wherein the subject is irradiated with visible light for at least about 30 seconds.
43 . The method of claim 42 , wherein the subject is irradiated with visible light for at least about 40 seconds.
44 . The method of claim 37 , wherein the macromer is polymerized by irradiating the subject with blue-green light.
45 . The method of claim 37 , wherein the macromer is polymerized by irradiating the subject with thermal energy.
46 . The method of claim 37 , wherein the water soluble polymer is PEG.
47 . The method of claim 46 , wherein the PEG has a molecular weight of from about 10,000 to about 35,000 Daltons.
48 . The method of claim 37 , wherein the macromer is biodegradable.
49 . The method of claim 37 , wherein the macromer comprises a plurality of hydrolysable linkages.
50 . The method of claim 49 , wherein the hydrolyzable linkages are selected from the group consisting of esters or carbonates.
51 . The method of claim 37 , wherein the water soluble polymer is modified with an poly (L-lactide) and poly (trimethylene carbonate) and an acrylate endcap.
52 . The method of claim 51 , wherein the water soluble polymer is PEG.
53 . The method of claim 37 , wherein the composition further comprises a photo-initiator.
54 . The method of claim 53 , wherein the photoinitiator is a dye.
55 . The method of claim 54 , wherein the dye is eosin.
56 . The method of claim 37 , wherein the composition further comprises a rheology modifier.
57 . The method of claim 56 , wherein the rheology modifier is HA or CMC.
58 . The method of claim 37 , wherein the composition is substantially free of organic solvent.
59 . The method of claim 37 , wherein the hydrogel has a strain or elongation before fracture substantially similar to the expected strain during normal use of the soft tissue to which it augments or repairs.
60 . The method of claim 37 , wherein the hydrogel has a strain or elongation before fracture greater than the expected strain during normal use of the soft tissue to which it augments or repairs.
61 . The method of claim 37 , wherein the hydrogel has a reversible elongation at least about 150% as great as an expected strain of the soft tissue which is augments or repairs.
62 . The method of claim 37 , wherein the hydrogel has an elastic modulus which is less than about 150 kPa.
63 . The method of claim 37 , wherein the hydrogen has an ultimate yield stress of from about 500 to about 2,000 psi.
64 . The method of claim 37 , wherein the macromer is injected subdermally.
65 . The method of claim 64 , wherein the macromer is polymerized by irradiating least a part of the skin of the subject.
66 . The method of claim 65 , wherein the skin is irradiated for at least about 30 seconds.
67 . The method of claim 66 , wherein the macromer is injected intradermally.
68 . The method of claim 67 , wherein the macromer is polymerized by irradiating at least a part of the skin of the subject.
69 . The method of claim 68 , wherein the skin is irradiated for at least about 30 seconds.
70 . The method of claim 37 , further comprising shaping the macromer.
71 . The method of claim 70 , wherein the macromer is shaped during polymerization of the macromer.
72 . The method of claim 71 , wherein the macromer is polymerized by irradiating through the skin of the subject.
73 . The method of claim 37 , comprising repeating steps a) and b) of claim 1 at least one time.
74 . The method of claim 37 , comprising repeating steps a) and b) of claim 1 at least two times.
75 . The method of claim 37 , wherein the subject is a mammal.
76 . The method of claim 75 , wherein the subject is a human.
77 . The method of claim 37 , the method comprising repairing facial tissue.
78 . The method of claim 77 , the method comprising decreasing the appearance of at least one facial line, wrinkle, crease, or fold.
79 . The method of claim 37 , the method comprising augmenting breast, lip, cheek, chin, forehead, buttocks, hand, neck or earlobe tissue in a subject.
80 . The method of claim 37 , the method comprising decreasing the appearance of a dermal dimple.
81 . The method of claim 80 , wherein the dimple is a component of a scar.
82 . The method of claim 37 , wherein the composition is administered with a red tinted syringe.
83 . The method of claim 37 , wherein the soft tissue remains substantially augmented or repaired for at least about 1 month.
84 . The method of claim 83 , wherein the soft tissue remains substantially augmented or repaired for at least about 2 months.
85 . The method of claim 84 , wherein the soft tissue remains substantially augmented or repaired for at least about 6 months.
86 . The method of claim 37 , wherein the hydrogel elicits a mild fibrotic response in the subject.
87 . The method of claim 37 , wherein the composition comprises a two part system, and wherein the polymerization is initiated via a redox system.
88 . The method of claim 87 , wherein the polymerization occurs over a period of from about 30 seconds to about 2 minutes.
89 . The method of claim 37 , wherein the composition further comprises a drug such as an non-steroidal anti-inflammatory, an analgesic, a vitamin such as E, C, A, D or K, an anti-oxidant, an alpha hydroxyl acid such as lactic acid or a polymer capable of releasing such drug, vitamin, anti oxidant or alpha-hydroxyacid or any combination thereof.
90 . A method of repairing or augmenting soft tissue in a subject, the method comprising a. injecting into a subject in need thereof a composition comprising a biodegradable, polymerizable macromer, the macromer comprising a water soluble polymer modified with one or more biodegradable moieties; and b. polymerizing the macromer to provide a hydrogel, thus repairing or augmenting the soft tissue.Join the waitlist — get patent alerts
Track US2011002997A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.